We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Effect of a 5-Day Regimen on Peripheral Stem Cell Mobilization

- Healthy Participants
- Terminated

Study Title: Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants

Teva Identifier: TV44688-ONC-30054

ClinicalTrials.gov Identifier: NCT03029000

Study Status: Terminated

Trial Condition(s): Healthy Participants

Interventions: Drug: Tbo-filgrastim

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

disease icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 60 Years

Trial Duration: August 2, 2017 - October 30, 2017

Phase: Phase 3

Study Type

Interventional